POZ Exclusives : If HIV Meds Grew On Trees - by Nicole Joseph

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » POZ Exclusives » August 2006

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Web Exclusives

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

August 9, 2006

If HIV Meds Grew On Trees

by Nicole Joseph

What if everyone with HIV were put on meds, not necessarily to protect their own health but to reduce the risk of spreading the virus to others? Researchers at the University of British Columbia (UBC) are making that radical proposal and fielding some tough questions.

“Even really motivated patients have difficulty with adherence,” says New York City HIV specialist Lloyd Bailey, MD, who wonders how he’d handle that problem with patients who don’t want to be on drugs in the first place—not to mention convincing them to tolerate the often difficult side effects. He fears a spike in drug resistance worldwide.

And how realistic is mass treatment? “We can’t even get condoms to people who want to use them to prevent HIV,” says Julie Davids of the New York-based advocacy group Community HIV/AIDS Mobilization Project (CHAMP). “How are we going to get them drugs?”

The UBC researchers—led by Julio Montaner, MD, who next week begins his term as president-elect of International AIDS Society at the International AIDS Conference in Toronto—propose that doling out treatment even to those that don’t “need” it under current standards would cripple the disease by lowering their viral loads and, in turn, their ability to infect others. In 45 years, they say, the number of HIV positive people worldwide would drop from 38 million to just one million.

Dr. Montaner told POZ that "there’s a continuous push back and forth [now] between prevention and treatment, and I think the time has come to move beyond that and recognize that prevention and treatment now synergize to reduce HIV transmission."

He also believes that it’s a better way to spend money in the long run. “Our exercise suggests that while antiretroviral therapy is highly cost effective on a patient-centered basis, it can also afford you twice as much savings if you look at what it can do in decreasing transmission of HIV.”

Dr. Bailey is among many who consider Dr. Montaner’s idea worthy of discussion but fear for the needs and rights of individual patients. They’re waiting to hear more when Dr. Montaner delivers a speech on the subject next Wednesday, August 16th in Toronto.

“I think that it merits testing in a formal fashion,” agrees Shaffiq Essajee, MD, a pediatrician who spends several months a year treating HIV positive children at a clinic in Mombasa, Kenya, and is senior adviser in pediatrics at the Clinton Foundation’s HIV/AIDS Initiative.

However, with only about 17% of sub-Saharan Africans having access to the HIV treatment they need, “Clinics are already full to overflowing,” says Dr. Essajee. And even in the U.S., he asks, “What sort of capacity is there to absorb that many folks on treatment?”


[Go to top]

Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV 101
HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
Disclosing Your Status
Starting Treatment
Search for the Cure
POZ Stories
POZ TV
Read the Blogs
Visit the Forums
Women
African American
Latino
Providers
Job Listings
Events Calendar


    andais
    Red House
    West Virginia


    mtaj0818
    Washington
    DC


    jimmy807
    San Antonio
    Texas


    clintonjrsyr
    syracuse
    New York
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Can social media help stop HIV stigma?
Yes
No

Survey
Mind Matters

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.